Literature DB >> 23720754

microRNA-7 suppresses the invasive potential of breast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8.

Na Yu1, Peiwei Huangyang, Xiaohan Yang, Xiao Han, Ruorong Yan, Hongti Jia, Yongfeng Shang, Luyang Sun.   

Abstract

SET8 (SET domain containing 8) is a histone H4 lysine 20 (H4K20)-specific monomethyltransferase in higher eukaryotes that exerts diverse functions in transcription regulation, DNA repair, tumor metastasis, and genome integrity. The activity of SET8 is tightly controlled during cell cycle through post-translational modifications, including ubiquitination, phosphorylation, and sumoylation. However, how the expression of SET8 is regulated is not fully understood. Here, we report that microRNA-7 is a negative regulator of SET8. We demonstrated that microRNA-7 inhibits H4K20 monomethylation and suppresses epithelial-mesenchymal transition and the invasive potential of breast cancer cells. We showed that microRNA-7 promotes spontaneous DNA damages and sensitizes cells to induced DNA damages. Our experiments provide a molecular mechanism for the regulation of SET8 and extend the biological function of microRNA-7 to DNA damage response, supporting the pursuit of microRNA-7 as a potential target for breast cancer intervention.

Entities:  

Keywords:  Breast Cancer; DNA Damage; DNA Damage Response; Epithelial Mesenchymal Transition; MicroRNA; MicroRNA-7; SET8

Mesh:

Substances:

Year:  2013        PMID: 23720754      PMCID: PMC3707664          DOI: 10.1074/jbc.M113.475657

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Genomic imprinting and epigenetic control of development.

Authors:  Andrew Fedoriw; Joshua Mugford; Terry Magnuson
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-07-01       Impact factor: 10.005

2.  miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells.

Authors:  GuoQiang Sun; Peng Ye; Kiyohito Murai; Ming-Fei Lang; Shengxiu Li; Heying Zhang; Wendong Li; Chelsea Fu; Jason Yin; Allen Wang; Xiaoxiao Ma; Yanhong Shi
Journal:  Nat Commun       Date:  2011-11-08       Impact factor: 14.919

3.  SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities.

Authors:  Fen Yang; Luyang Sun; Qian Li; Xiao Han; Liandi Lei; Hua Zhang; Yongfeng Shang
Journal:  EMBO J       Date:  2011-10-07       Impact factor: 11.598

4.  MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.

Authors:  Dawn R Cochrane; Diana M Cittelly; Erin N Howe; Nicole S Spoelstra; Erin L McKinsey; Kelly LaPara; Anthony Elias; Douglas Yee; Jennifer K Richer
Journal:  Horm Cancer       Date:  2010-12       Impact factor: 3.869

5.  Identification of DNA methylation changes associated with human gastric cancer.

Authors:  Jung-Hoon Park; Jinah Park; Jung Kyoon Choi; Jaemyun Lyu; Min-Gyun Bae; Young-Gun Lee; Jae-Bum Bae; Dong Yoon Park; Han-Kwang Yang; Tae-You Kim; Young-Joon Kim
Journal:  BMC Med Genomics       Date:  2011-12-02       Impact factor: 3.063

6.  Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells.

Authors:  Kammei Rai; Nagio Takigawa; Sachio Ito; Hiromi Kashihara; Eiki Ichihara; Tatsuji Yasuda; Kenji Shimizu; Mitsune Tanimoto; Katsuyuki Kiura
Journal:  Mol Cancer Ther       Date:  2011-06-28       Impact factor: 6.261

7.  microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.

Authors:  N Zhang; X Li; C W Wu; Y Dong; M Cai; M T S Mok; H Wang; J Chen; S S M Ng; M Chen; J J Y Sung; J Yu
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

8.  Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

9.  The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin.

Authors:  Iwona Driskell; Hisanobu Oda; Sandra Blanco; Elisabete Nascimento; Peter Humphreys; Michaela Frye
Journal:  EMBO J       Date:  2011-11-25       Impact factor: 11.598

10.  Regulation of pancreatic microRNA-7 expression.

Authors:  Sharon Kredo-Russo; Avital Ness; Amitai D Mandelbaum; Michael D Walker; Eran Hornstein
Journal:  Exp Diabetes Res       Date:  2012-05-17
View more
  19 in total

1.  Histone methyltransferase Setd8 represses Gata2 expression and regulates erythroid maturation.

Authors:  Jeffrey Malik; Michael Getman; Laurie A Steiner
Journal:  Mol Cell Biol       Date:  2015-04-06       Impact factor: 4.272

Review 2.  The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.

Authors:  Ulrich H Weidle; Steffen Dickopf; Corinna Hintermair; Gwendlyn Kollmorgen; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

3.  A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle.

Authors:  Nana Zheng; Xiangpeng Dai; Zhiwei Wang; Wenyi Wei
Journal:  Cell Cycle       Date:  2016-09-20       Impact factor: 4.534

Review 4.  Chromatin modifications during repair of environmental exposure-induced DNA damage: a potential mechanism for stable epigenetic alterations.

Authors:  Heather M O'Hagan
Journal:  Environ Mol Mutagen       Date:  2013-11-20       Impact factor: 3.216

5.  Distinct developmental phenotypes result from mutation of Set8/KMT5A and histone H4 lysine 20 in Drosophila melanogaster.

Authors:  Aaron T Crain; Stephen Klusza; Robin L Armstrong; Priscila Santa Rosa; Brenda R S Temple; Brian D Strahl; Daniel J McKay; A Gregory Matera; Robert J Duronio
Journal:  Genetics       Date:  2022-05-31       Impact factor: 4.402

6.  Benzyl and phenethyl isothiocyanates as promising epigenetic drug compounds by modulating histone acetylation and methylation marks in malignant melanoma.

Authors:  Melina Mitsiogianni; Ioannis Anestopoulos; Sotiris Kyriakou; Dimitrios T Trafalis; Rodrigo Franco; Aglaia Pappa; Mihalis I Panayiotidis
Journal:  Invest New Drugs       Date:  2021-05-08       Impact factor: 3.850

Review 7.  MicroRNA-7: a promising new target in cancer therapy.

Authors:  Juanjuan Zhao; Yijing Tao; Ya Zhou; Nalin Qin; Chao Chen; Dan Tian; Lin Xu
Journal:  Cancer Cell Int       Date:  2015-10-29       Impact factor: 5.722

8.  Expression Patterns of Circular RNAs from Primary Kinase Transcripts in the Mammary Glands of Lactating Rats.

Authors:  ChunLei Zhang; Hui Wu; YanHong Wang; YuLong Zhao; XingTang Fang; CaiFa Chen; Hong Chen
Journal:  J Breast Cancer       Date:  2015-09-24       Impact factor: 3.588

9.  Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers.

Authors:  Zhen Liu; Chunping Mai; Huiling Yang; Yan Zhen; Xiaoli Yu; Shengni Hua; Qiangyun Wu; Qinping Jiang; Yajie Zhang; Xin Song; Weiyi Fang
Journal:  J Cell Mol Med       Date:  2014-06-26       Impact factor: 5.310

10.  SCF(β-TRCP) promotes cell growth by targeting PR-Set7/Set8 for degradation.

Authors:  Zhiwei Wang; Xiangpeng Dai; Jiateng Zhong; Hiroyuki Inuzuka; Lixin Wan; Xiaoning Li; Lixia Wang; Xiantao Ye; Liankun Sun; Daming Gao; Lee Zou; Wenyi Wei
Journal:  Nat Commun       Date:  2015-12-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.